• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

embecta

Embecta eyes shift from insulin delivery to broader medical supplies focus

May 22, 2025 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications. The pure-play diabetes technology company has endured ups and downs since its 2022 spin-off from BD. That includes an FDA approval for a disposable insulin patch pump system in September 2024, only to be followed by the discontinuation […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Wall Street Beat Tagged With: embecta

Embecta to undergo further restructuring, lowers guidance amid tariff impact

May 9, 2025 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) stock was down today after news of restructuring and mixed second-quarter results. Shares of EMBC were down more than 8% to $12.12 apiece near the close of trading today. While the company continues to work through the discontinuation of its insulin patch pump program — the plan for which it says is substantially […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology Tagged With: embecta

Embecta shares study highlighting need for training, standardization in insulin delivery

April 2, 2025 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) announced a new publication introducing best practices for insulin injection techniques and education. The publication in the Mayo Clinic Proceedings introduces the FITTER Forward Expert Recommendations. These best practices, authored by a panel of 16 diabetes specialists from 13 countries, highlight the critical need for improved training and standardization in insulin delivery. It […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: embecta

Embecta stock rises on Street-beating Q1, patch pump continuation remains on track

February 6, 2025 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) shares ticked up before hours today on first-quarter results that came in ahead of the consensus forecast. Shares of EMBC rose 1.65% to $18.50 apiece in pre-market trading today. The Parsippany, New Jersey-based diabetes technology company reported profits of $157.1 million. That equals $0 per share on sales of $261.9 million for the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: embecta

Analysts say Embecta is ‘heading in the right direction’ following patch pump discontinuation

January 16, 2025 By Sean Whooley

BD Diabetes Spinoff Embecta

Analysts called a recent stock sell-off at Embecta (Nasdaq:EMBC) “unwarranted” and believe the company is moving in the right direction despite recent challenges. Late last year, Embecta filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees. This related to the company’s plans to discontinue its insulin patch pump program and restructure. […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Technology, Wall Street Beat Tagged With: embecta

Embecta to lay off 118 in Massachusetts following patch pump program discontinuation

December 5, 2024 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees. The state received Embecta’s Worker Adjustment and Retraining Notification (WARN) submission on Nov. 26 — the same day it announced plans to discontinue its insulin patch pump program and restructure. The discontinuation of the patch pump program came not […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: embecta, Personnel Moves

Embecta discontinues insulin patch pump program, plans restructuring

November 26, 2024 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan. Shares of EMBC ticked up 4.3% to $14.41 apiece before hours after the company announced the discontinuation as part of its fourth-quarter earnings results. The BD Diabetes spinoff won FDA approval for a disposable patch pump system […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: embecta

The biggest diabetes tech stories of the year so far

November 14, 2024 By Sean Whooley

ADA 2024 Product Images Dexcom Abbott Senseonics Ascensia Insulet Tandem Medtronic Sequel

On World Diabetes Day, it’s worth taking a look back at the last 10.5 months in the diabetes technology space. The date, which marks the birth date of the inventor of insulin, brings out all sorts of initiatives from various companies involved in innovating these technologies (read about those HERE). Those companies have contributed to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pain Management, Technology Tagged With: abbott, Dexcom, embecta, Insulet, Medtronic, National Diabetes Awareness Month 2024, Roche, Roche Diabetes Care, Senseonics, Sequel Med Tech, Tandem Diabetes Care, World Diabetes Day 2024

What diabetes tech companies are doing on World Diabetes Day 2024

November 14, 2024 By Sean Whooley

World Diabetes day

World Diabetes Day — today, Nov. 14 — brings out the best in the diabetes community that continues to innovate year after year. This date serves as a time to recognize these innovations as it marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. The […]

Filed Under: Diabetes, Drug-Device Combinations, Featured Tagged With: abbott, Ascensia Diabetes Care, Dexcom, embecta, Fresenius Medical Care, Insulet, Medtronic, National Diabetes Awareness Month 2024, World Diabetes Day 2024

Embecta wins FDA clearance for disposable insulin patch pump

September 3, 2024 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) announced today that it received FDA 510(k) clearance for its proprietary disposable insulin delivery system. The open-loop system is indicated for adults who require insulin to manage diabetes, including both type 1 and type 2 diabetes. It features a tubeless design with a 300-unit insulin reservoir, informed by feedback from people with type […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Technology Tagged With: embecta, FDA

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 5
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS